Vriens, Ingeborg J. H.
ter Welle-Butalid, Elena M.
de Boer, Maaike
de Die-Smulders, Christine E. M.
Derhaag, Josien G.
Geurts, Sandra M. E.
van Hellemond, Irene E. G.
Luiten, Ernest J. T.
Dercksen, M. Wouter
Lemaire, Bea M. D.
van Haaren, Els R. M.
Vriens, Birgit E. P. J.
van de Wouw, Agnes J.
van Riel, Anne-marie M. G. H.
Janssen-Engelen, Sandra L. E.
van de Poel, Marlène H. W.
Schepers-van der Sterren, Ester E. M.
van Golde, Ron J. T.
Tjan-Heijnen, Vivianne C. G.
Funding for this research was provided by:
Pink Ribbon Foundation The Netherlands (2008.C42)
Article History
Received: 17 January 2020
Accepted: 12 March 2020
First Online: 31 March 2020
Compliance with ethical standards
:
: Vivianne C.G. Tjan-Heijnen received research grants from AstraZeneca, Novartis, Pfizer, Roche, Eisai, and E. Lily. Honorarium or other (financial) fees: Roche, Novartis, and E. Lily. The remaining authors have no disclosures.
: All procedures performed in this study were in accordance with the ethical standards of institutional and/or national research committee and with the 1964 Helsinki declaration and its later amendments or comparable ethical standards.
: According to the Netherlands Central Committee on Research Involving Human Subjects guidelines, this observational study is not subject to the Act on Medical Research Involving Human Subjects and therefore informed consent is not obtained for patients included in this study.